首页> 外国专利> WATER SOLUBLE AZOLES AS BROAD-SPECTRUM ANTIFUNGALS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

WATER SOLUBLE AZOLES AS BROAD-SPECTRUM ANTIFUNGALS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

机译:水溶性偶氮类作为广谱抗真菌剂,其制备方法和组成它们的药物成分

摘要

A compound of the formula a N-oxide form, a pharmaceutically acceptable addition salt or a stereochemically isomeric form thereof, wherein L represents a radical of formula wherein each Alk independently represents C1-6 alkanediyl optionally substituted with hydroxy or C1-4 alkyloxy; each n independently is 1, 2 or 3; Y represents O, S or NR2; each R1 independently represents hydrogen, aryl, Het1, or C1-6 alkyl optionally substituted with one, two or three substituents each independently selected from halo, hydroxy, mercapto, C1-4 alkyloxy, C1-4 alkylthio, aryloxy, arylthio, aryl C1-4 alkyloxy, aryl C1-4 alkylthio, cyano, amino, mono- or diC1-4 alkyl)-amino, mono- or di(aryl)amino, mono- or di(aryl C1-4 alkyl)amino, C1-4 alkyloxycarbonylamino, benzyloxycarbonylamino, aminocarbonyl, carboxyl, C1-4 alkyloxycarbonyl, guanidinyl, aryl or Het2; each R2 independently represents hydrogen or C1-6 alkyl; or in case R1 and R2 are attached to the same nitrogen atom, they 2718 י" ב בתשרי התשס" ה - September 27, 2004 may be taken together to form a heterocyclic radical selected from morpholinyl, pyrrolidinyl, piperidinyl, homopiperidinyl or piperazinyl; said heterocyclic radical may optionally be substituted with C1-4 alkyl, aryl, Het2 aryl C1-4 alkyl, Het2 C1-4 alkyl, hydroxy C1-4 alkyl, amino, mono- or di(C1-4 alkyl) amino, amino C1-4 alkyl, mono or di(C1-4 alkyl) amino C1-4 alkyl, carboxy, aminocarbonyl, C1-4 alkyloxycarbonyl, C1-4 alkyloxycarbonylamino or mono- or di(C1-4 alkyl) aminocarbonyl; or they may be taken together to form an azido radical; each R3 indepenently represents hydrogen, hydroxy or C1-4 alkyloxy; aryl represents phenyl, naphthalenyl, 1,2,3,4-tetrahydro- naphthalenyl, indentyl or indanyl; each of said aryl groups may optionally be substituted with one or more substituents selected from halo, C1-4 alkyl, hydroxy, C1-4 alkyloxy, nitro, amino, trifluoromethyl, hydroxy C1-4 alkyl, C1-4 alkyloxy C1-4 alkyl, amino C1-4 alkyl, mono- or di(C1-4 alkyl) amino C1-4 alkyl; Het1 represents a monocyclic or bicyclic heterocyclic radical; said monocyclic heterocyclic radical being selected from the group pyridinyl, piperidinyl, homopiperidinyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, triazolyl, pyranyl, tetrahydropyranyl, imidazolyl, imidazolinyl, imidazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, thiazolyl, thiazolidinyl, isothiazolyl, oxazolyl, oxazolidinyl, isoxazolyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, furanyl, tetrahydrofuranyl, thienyl, thiolanyl, dioxolanyl; said bicyclic heterocyclic radical being selected from the group quinolinyl, 1,2,3,4-tetrahydro- quinolinyl, isoquinolinyl, quinoxalinyl, quinazolinyl, phtalazinyl, cinnolinyl, chromanyl, thiochromanyl, 2H-chromenyl, 1,4-benzodioxanyl, indolyl, isoindolyl, indolinyl, indazolyl, purinyl, pyrrolopyridinyl, furanopyridinyl, thienopyridinyl, benzothiazolyl, benzoxazolyl, benzisothiazolyl, benzisoxazolyl, benzimidazolyl, benzofuranyl, benzothienyl; whereby each of said mono- or bicyclic heterocycle may optionally be substituted with one or where possible more substituents selected from halo, C1-4 alkyl, hydroxy, C1-4 alkyloxy, nitro, amino, trifluoromethyl, hydroxy C1-4 alkyl, C1-4 alkyloxy-C1-4 alkyl, amino C1-4 alkyl, mono- or di(C1-4 alkyl) amino C1-4 alkyl, aryl or aryl C1-4 alkyl; Het2 is the same as Het1 and may also be a monocyclic heterocycle selected from piperazinyl, homopiperazinyl, 1,4-dioxanyl, morpholinyl, thiomorpholinyl, whereby each of said monocyclic heterocycle may optionally be substituted with one or where possible more substituents selected from halo, C1-4 alkyl, hydroxy, C1-4 alkyloxy, nitro, amino, trifluoromethyl, hydroxy C1-4 alkyl, C1-4 alkyloxy C1-4 alkyl, amino C1-4 alkyl, mono- or di-(C1-4 alkyl) amino C1-4 alkyl, aryl or aryl C1-4 alkyl; R6 represents hydrogen or C1-4 alkyl; R7 represents hydrogen or C1-4 alkyl; or R6 and R7 taken together form a bivalent radical of formula -R6-R7- wherein -R6-R7- is: -N=CH-(i), -CH=N-(ii), -CH=CH-(iii, -CH2-CH2(iv), wherein one hydrogen atom in the radical (i) and (ii) may be replaced with a C1-4 alkyl radical and one or more hydrogen atoms in radicals (iii) and (iv) may be replaced by a C1-4 alkyl radical; D represents hydrogen or a radical of formula 2719 י" ב בתשרי התשס" ה - September 27, 2004 wherein X is N or CH; R4 is hydrogen or halo; R5 is halo; provided that if D is hydrogen R6 and R7 are not hydrogen.
机译:式为N-氧化物的化合物,其药学上可接受的加成盐或其立体化学异构体形式,其中L表示下式的基团,其中每个Alk独立地表示任选地被羟基或C1-4烷氧基取代的C1-6烷二烷基;每个n独立为1、2或3; Y代表O,S或NR 2;每个R 1独立地表示氢,芳基,Het 1或任选被一个,两个或三个取代基取代的C 1-6烷基,所述取代基各自独立地选自卤素,羟基,巯基,C 1-4烷氧基,C 1-4烷硫基,芳氧基,芳硫基,芳基C1 -4烷氧基,芳基C1-4烷硫基,氰基,氨基,单或二C 1-4烷基)-氨基,单或二(芳基)氨基,单或二(芳基C1-4烷基)氨基,C 1-4烷氧基羰基氨基,苄氧基羰基氨基,氨基羰基,羧基,C 1-4烷氧基羰基,胍基,芳基或Het 2;每个R 2独立地代表氢或C 1-6烷基;或者如果R1和R2连接在相同的氮原子上,则它们可以一起形成2004年9月27日的杂环基,选自吗啉基,吡咯烷基,哌啶基,高哌啶基或哌嗪基;所述杂环基可以任选地被C 1-4烷基,芳基,Het 2芳基C 1-4烷基,Het 2 C 1-4烷基,羟基C 1-4烷基,氨基,单或二(C 1-4烷基)氨基,氨基C 1取代-4烷基,单或二(C 1-4烷基)氨基,C 1-4烷基,羧基,氨基羰基,C 1-4烷氧羰基,C 1-4烷氧羰基氨基或单或二(C 1-4烷基)氨基羰基;或者它们可以合在一起形成叠氮基。每个R 3独立地表示氢,羟基或C 1-4烷氧基。芳基代表苯基,萘基,1,2,3,4-四氢萘基,茚基或茚满基;每个所述芳基可任选地被一个或多个选自卤素,C 1-4烷基,羟基,C 1-4烷氧基,硝基,氨基,三氟甲基,羟基C 1-4烷基,C 1-4烷氧基C 1-4烷基的取代基取代。氨基C 1-4烷基,单或二(C 1-4烷基)氨基C 1-4烷基; Het1表示单环或双环杂环基团;所述单环杂环基选自吡啶基,哌啶基,高哌啶基,吡嗪基,嘧啶基,哒嗪基,三嗪基,三唑基,吡喃基,四氢吡喃基,咪唑基,咪唑啉基,咪唑啉基,吡唑基,吡唑基,吡唑烷基,吡唑烷基,吡唑烷基,吡唑烷基,异恶唑基,吡咯基,吡咯烷基,吡咯烷基,呋喃基,四氢呋喃基,噻吩基,硫杂环戊基,二氧杂环戊基;所述双环杂环基选自喹啉基,1,2,3,4-四氢喹啉基,异喹啉基,喹喔啉基,喹唑啉基,邻苯二甲酰基,肉桂啉基,苯并二氢吡喃基,硫代苯并吡喃基,2H-苯并,1,4-苯并二恶烷基, ,吲哚基,吲唑基,嘌呤基,吡咯并吡啶基,呋喃并吡啶基,噻吩并吡啶基,苯并噻唑基,苯并恶唑基,苯并异噻唑基,苯并异唑基,苯并咪唑基,苯并呋喃基,苯并噻吩基;其中每个所述单环或双环杂环可以任选地被一个或在更多可能的情况下取代基取代,所述取代基选自卤素,C1-4烷基,羟基,C1-4烷氧基,硝基,氨基,三氟甲基,羟基C1-4烷基,C1- 4烷氧基-C 1-4烷基,氨基C 1-4烷基,单或二(C 1-4烷基)氨基C 1-4烷基,芳基或芳基C 1-4烷基; Het2与Het1相同,也可以是选自哌嗪基,高哌嗪基,1,4-二恶烷基,吗啉基,硫代吗啉基的单环杂环基,其中每个所述单环杂环基可任选被一个或多个选自卤素的取代基取代, C 1-4烷基,羟基,C 1-4烷氧基,硝基,氨基,三氟甲基,羟基C 1-4烷基,C 1-4烷氧基C 1-4烷基,氨基C 1-4烷基,单或二-(C 1-4烷基)氨基C 1-4烷基,芳基或芳基C 1-4烷基; R6代表氢或C1-4烷基; R7代表氢或C1-4烷基;或R 6和R 7一起形成式-R 6 -R 7-的二价基团,其中-R 6 -R 7-为:-N = CH-(i),-CH = N-(ii),-CH = CH-(iii ,-CH 2 -CH 2(iv),其中基团(i)和(ii)中的一个氢原子可以被C 1-4烷基取代,基团(iii)和(iv)中的一个或多个氢原子可以是-由C1-4烷基取代; D表示氢或式2719的基团-2004年9月27日,其中X为N或CH; R4为氢或卤素; R5为卤素; D是氢,R 6和R 7不是氢。

著录项

  • 公开/公告号IL139649B

    专利类型

  • 公开/公告日2004-09-27

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA N.V.;

    申请/专利号IL139649

  • 发明设计人

    申请日2000-11-13

  • 分类号

  • 国家 IL

  • 入库时间 2022-08-21 23:10:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号